Skip to Main Content

First Regeneron trial began at Holy Name Medical Center

Holy Name Medical Center launched Regeneron's clinical trial for the experimental antibody

10/05/2020

NJ Spotlight News

First Regeneron trial began at Holy Name Medical Center

Clip: 10/5/2020 | 3m 9sVideo has Closed Captions

Holy Name Medical Center launched Regeneron's clinical trial for the experimental antibody

Holy Name Medical Center launched Regeneron's clinical trial for the experimental antibody cocktail. It's reportedly the same treatment the president received. One Holy Name trial subject improved three days after either receiving the treatment or a placebo.

10/05/2020

Problems playing video?   | Closed Captioning Feedback

Report a Problem

Before you submit an error, please consult our Video Help page.

Problems playing video?   | Closed Captioning Feedback

Report a Problem

Before you submit an error, please consult our Video Help page.

NJ Spotlight News is a local public television program presented by THIRTEEN PBS

Business Report: home sales rise, movie theaters close

Video has Closed Captions

Clip: 10/5/2020 | 2m 36s | Business Correspondent Rhonda Schaffler brings you today's New Jersey business news. (2m 36s)

Murphy: Trump put lives at risk by holding NJ fundraiser

Video has Closed Captions

Clip: 10/5/2020 | 3m 49s | Murphy accused President Trump of putting "lives at risk" by holding a fundraiser in NJ. (3m 49s)

Parents push back on district school reopening plans

Video has Closed Captions

Clip: 10/5/2020 | 3m 9s | Parents across the state are pushing back on districts’ remote learning plans. (3m 9s)

Will the show go on for New Jersey's arts scene?

Video has Closed Captions

Clip: 10/5/2020 | 3m 11s | Estimates say the nonprofit arts sector in NJ took a $60M hit since the start of COVID-19. (3m 11s)

Providing Support for PBS.org

Learn Moreabout PBS online sponsorship

Support for PBS provided by:

NJ Spotlight News is a local public television program presented by THIRTEEN PBS

Sign in with Email

or

Continue with GoogleContinue with FacebookContinue with Apple

By creating an account, you acknowledge that PBS may share your information with our member stations and our respective service providers, and that you have read and understand the Privacy Policy and Terms of Use.

Are you sure you want to remove null from My List?